BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

R-Tech Ueno 

10F, Yamato Life Insurance Building
1-1-7 Uchisaiwaicho, Chiyoda-ku
Tokyo    100-0011  Japan
Phone: 81-3-3596-8011 Fax: 81-3-3596-8023


SEARCH JOBS










 Company News
R-Tech Ueno: Sucampo Pharmaceuticals, Inc. (SCMP) And Takeda (TKPYY) Enter Into Global Licensing Agreement For AMITIZA® (Lubiprostone) 10/23/2014 11:18:09 AM
R-Tech Ueno: Announcement Of Initiation Of The Phase I Clinical Trial For The Novel VAP-1 Inhibitor RTU-1096 10/20/2014 9:27:54 AM
R-Tech Ueno: Settlement Agreement That Resolves Patent Litigation In U.S. Related To AMITIZA® And Company Receives Additional Paragraph IV Notice 10/10/2014 8:29:50 AM
R-Tech Ueno: Announcement Of Collaborative Research With Keio University For Treatment Of Graft-Versus-Host Disease (GVHD) 3/11/2014 9:11:39 AM
R-Tech Ueno Release: Announcement of the Completion of Stage I and the Start of Enrollment for Stage II of the Phase I/II Clinical Trial of Genetically Recombinant Human Serum Albumin (Code: RU-101) Ophthalmic Solution for the Treatment of Severe Dry Eye in the US 11/8/2013 8:11:05 AM
R-Tech Ueno: Start of the Patient Enrollment of a Phase I/II Clinical Study of Recombinant Human Serum Albumin-Containing Ophthalmic Solution (Development Code: RU-101) in U.S. for the Treatment of Severe Dry Eye 5/20/2013 10:46:40 AM
R-Tech Ueno Receives FDA IND Approval for RU-101 (r-HSA) to Treat Severe Dry Eye 4/26/2013 10:10:16 AM
R-Tech Ueno: Start of the Patient Enrollment of a Phase 3 Clinical Study of Unoprostone (Development Code UF-021) Ophthalmic Solution for the Treatment of Retinitis Pigmentosa 3/18/2013 10:27:16 AM
R-Tech Ueno: Announcement of Commercial Availability of RESCULA® Eye Drops in the U.S. Market 2/21/2013 9:09:39 AM
R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA® Capsules Patents 2/12/2013 10:06:08 AM
1234